Hepatobiliary manifestations of inflammatory bowel disease in children

被引：6
作者：
Kucharska, Magdalena [1 ]
Daniluk, Urszula [1 ]
Kwiatek-Sredzinska, Kamila Agnieszka [1 ]
Wasilewska, Natalia [1 ]
Filimoniuk, Aleksandra [1 ]
Jakimiec, Piotr [1 ]
Zdanowicz, Katarzyna [1 ]
Lebensztejn, Dariusz Marek [1 ]
机构：
[1] Med Univ Bialystok, Dept Pediat Gastroenterol Hepatol Nutr & Allergol, 17 Jerzego Waszyngtona St, PL-15274 Bialystok, Poland
来源：
CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2019年 / 5卷 / 03期
关键词：
children; inflammatory bowel disease; Crohn's disease; ulcerative colitis; hepatobiliary manifestations; PRIMARY SCLEROSING CHOLANGITIS; HEPATITIS-B; EXTRAINTESTINAL MANIFESTATIONS; ULCERATIVE-COLITIS; PEDIATRIC-PATIENTS; OVERLAP SYNDROME; LIVER-DISEASE; VACCINATION; PREVALENCE; HEPATOTOXICITY;
D O I：
10.5114/ceh.2019.87632
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Inflammatory bowel disease (IBD) diagnosis and therapy is challenging for every pediatrician, especially when complicated with extraintestinal manifestations. The article reviews current literature on the hepatobiliary manifestations associated with inflammatory bowel disease in the pediatric population.
引用
收藏
页码：203 / 209
页数：7
相关论文
共 51 条
[1]   SULFASALAZINE FOR RHEUMATOID-ARTHRITIS - TOXICITY IN 774 PATIENTS MONITORED FOR ONE TO 11 YEARS [J].
AMOS, RS ;
PULLAR, T ;
BAX, DE ;
SITUNAYAKE, D ;
CAPELL, HA ;
MCCONKEY, B .
BMJ-BRITISH MEDICAL JOURNAL, 1986, 293 (6544) :420-423
[2]   Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: Study of 511 subjects at a single center [J].
Bargiggia, S ;
Maconi, G ;
Elli, M ;
Molteni, P ;
Ardizzone, S ;
Parente, F ;
Todaro, I ;
Greco, S ;
Manzionna, G ;
Porro, GB .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) :417-420
[3]   Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases [J].
Belle, Arthur ;
Baumann, Cedric ;
Bigard, Marc-Andre ;
Zallot, Camille ;
Gizard, Emmanuel ;
Gueant, Jean-Louis ;
Bronowicki, Jean-Pierre ;
Peyrin-Biroulet, Laurent .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (08) :877-881
[4]   SULFASALAZINE-INDUCED HEPATOTOXICITY IN CHILDREN WITH INFLAMMATORY BOWEL-DISEASE [J].
BOYER, DL ;
LI, BUK ;
FYDA, JN ;
FRIEDMAN, RA .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1989, 8 (04) :528-532
[5]  
Braun M, 1999, AM J GASTROENTEROL, V94, P1973
[6]   Infliximab Maintains Durable Response and Facilitates Catch-up Growth in Luminal Pediatric Crohn's Disease [J].
Church, Peter C. ;
Guan, Jack ;
Walters, Thomas D. ;
Frost, Karen ;
Assa, Amit ;
Muise, Aleixo M. ;
Griffiths, Anne M. .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (07) :1177-1186
[7]  
COHEN S, 1971, GASTROENTEROLOGY, V60, P237
[8]   Infliximab-Related Hepatitis: A Case Study and Literature Review [J].
Colina, Francisco ;
Molero, Aida ;
Casis, Begona ;
Martinez-Montiel, Pilar .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (11) :3362-3367
[9]   Mesalamine in pediatric inflammatory bowel disease: A 10-year experience [J].
DAgata, ID ;
Vanounou, T ;
Seidman, E .
INFLAMMATORY BOWEL DISEASES, 1996, 2 (04) :229-235
[10]   Primary Sclerosing Cholangitis, Autoimmune Hepatitis, and Overlap in Utah Children: Epidemiology and Natural History [J].
Deneau, Mark ;
Jensen, M. Kyle ;
Holmen, John ;
Williams, Marc S. ;
Book, Linda S. ;
Guthery, Stephen L. .
HEPATOLOGY, 2013, 58 (04) :1392-1400
123456